500 related articles for article (PubMed ID: 12688298)
1. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
Viana JM
Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
[No Abstract] [Full Text] [Related]
2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
3. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
4. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
5. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
6. Patent law--balancing profit maximization and public access to technology.
Beckerman-Rodau A
Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
[TBL] [Abstract][Full Text] [Related]
7. Global patent police block cost-reduction efforts.
Kasper T
GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
[TBL] [Abstract][Full Text] [Related]
8. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
9. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
10. Rights, patents, markets and the global AIDS pandemic.
Gathii JT
Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
[No Abstract] [Full Text] [Related]
11. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
12. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.
Schuklenk U
Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958
[No Abstract] [Full Text] [Related]
13. Patent immorality?
Bloche MG; Jungman ER
Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
[No Abstract] [Full Text] [Related]
14. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
15. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
16. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
17. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
18. Compulsory licenses and access to HIV/AIDS drugs.
Zuniga JM; Wilder R
IAPAC Mon; 2001 Dec; 7(12):328-32. PubMed ID: 11799944
[No Abstract] [Full Text] [Related]
19. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
20. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
